Home Newsfeeds FDA Briefing Document For Amylyx Pharmaceuticals’ AMX0035 (Full document)

FDA Briefing Document For Amylyx Pharmaceuticals’ AMX0035 (Full document)

https://www.fda.gov/media/161378/download

byBill Haddad

September 2, 2022

1 minute read

https://www.fda.gov/media/161378/download

M&A
News

Cleveland-Cliffs Issued Statement Regarding The Announced Proposed Acquisition Of U.S. Steel By Nippon Steel

By Benzinga Newsdesk

December 18, 10:27 AM

Lourenco Goncalves, Chairman, President of CEO of Cleveland-Cliffs, said, "We identified U.S. Steel as an extremely undervalued company with significant synergy potential when combined with Cleveland-Cliffs, creating a

CLF

Elon Musk Announces New AI Chatbot ‘Grok’ — And It’s Already Giving Its Peers A Run For Their Money

By Bibhu Pattnaik

November 5, 1:18 PM

Elon Musk's artificial intelligence enterprise, xAI, has released its inaugural AI model, the billionaire entrepreneur announced on X on Sunday.

GOOGL

Dow Jumps Over 800 Points, Volatility In Markets Decreases

By Lisa Levin

October 5, 4:51 AM

U.S. stocks closed higher for the second straight session on Tuesday, with the S&P 500 index recording its biggest single-session gain in two years. U.S. job openings declined by the most in around 2-1/2 years in August, while the Reserve Bank of Australia announced a smaller-than-expected rate increase of 25 basis points.

AAPL